NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cygnus Biosciences (Beijing) Co., Ltd.

Cygnus Biosciences (Beijing) Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://cygnusbio.com/

Last Round

VC Round

Oct 21, 2025

Total Funding Raised

$70.71M

Company Overview

Cygnus Biosciences (Beijing) Co., Ltd. is a biotechnology company that develops, produces, and markets gene sequencing instruments, reagents, and genomic solutions for research, medical diagnosis, and drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Biotechnology, Precision Medicine, Computing Hardware

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

gene sequencingDNA sequencernext-generation sequencingNGSsequencing reagentsgenomic dataclinical diagnosticsprecision medicinebioinformaticshigh-throughput sequencingerror-correction codeECCbiotech equipmentgenomics labsequencing consumables

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cygnus Biosciences (Beijing) Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Cygnus Biosciences (Beijing) Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cygnus Biosciences (Beijing) Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 21, 2025
Series C ExtensionMar 20, 2023
Series CJun 11, 2020
Series B ExtensionJun 12, 2018
Series BNov 14, 2017
Series A
Nov 1, 2015

Cygnus Biosciences (Beijing) Co., Ltd. Investors

Notable investors and investment history

Cygnus Biosciences (Beijing) Co., Ltd. investors
InvestorRounds
Beijing E-Town International Investment & Development Co., Ltd.Series C Extension, VC Round
Qiaojing CapitalSeries B Extension
Source Code CapitalSeries C Extension
Hotung Investment Holdings LimitedSeries C Extension
清控银杏创业投资管理(北京)有限公司Series B Extension
Zhongguancun Development GroupSeries B
Founder Hesheng Investment Co., Ltd.Series C Extension

Cygnus Biosciences (Beijing) Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cygnus Biosciences (Beijing) Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cygnus Biosciences (Beijing) Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range18
Year Founded2015
Last FundingOct 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.